Literature DB >> 9673264

Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults.

Q He1, N N Tran Minh, K Edelman, M K Viljanen, H Arvilommi, J Mertsola.   

Abstract

Pertussis infection is increasingly recognized in older children and adults, indicating the need of booster immunizations in these age groups. We investigated the induction of pertussis-specific immunity in schoolchildren and adults after booster immunization and natural infection. The expression of mRNA of gamma interferon (IFN-gamma), interleukin-2 (IL-2), IL-4, and IL-5 in the peripheral blood mononuclear cells (PBMCs) was assayed by reverse transcription-PCR. The PBMCs of 17 children immunized with one dose of an acellular vaccine containing pertussis toxin (PT), filamentous hemagglutinin (FHA), and pertactin (PRN) significantly proliferated in vitro after stimulation with the vaccine antigens. The PBMCs of seven infected individuals markedly proliferated in the presence of PT and FHA, but the cells of only two of these subjects responded to PRN. At least one of the antigens induced mRNA for IL-4 and/or IL-5 in the cells of 93% of tested vaccinees and patients, and FHA induced IFN-gamma mRNA in the cells of two-thirds of them. Expression of mRNA for IFN-gamma correlated with the production of the cytokine protein. Anti-FHA immunoglobulin G antibodies significantly correlated with FHA-induced proliferative responses both before and after immunization. These results show that booster immunization with acellular pertussis vaccine induces both antibody- and cell-mediated immune responses in schoolchildren. Further, booster immunization and natural infection seem to induce the expression of mRNA of T-helper 1 (Th1) and Th2 type cytokines in similar manners. This observation supports the use of acellular pertussis vaccines for booster immunizations of older children, adolescents, and adults.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673264      PMCID: PMC108420     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Invasion of HeLa 229 cells by virulent Bordetella pertussis.

Authors:  C A Ewanowich; A R Melton; A A Weiss; R K Sherburne; M S Peppler
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

2.  Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines.

Authors:  C M Ausiello; F Urbani; A la Sala; R Lande; A Cassone
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

3.  The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection.

Authors:  J D Nelson
Journal:  Am J Dis Child       Date:  1978-04

4.  Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.

Authors:  A Kimura; K T Mountzouros; D A Relman; S Falkow; J L Cowell
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

5.  Human cellular immune responses to Bordetella pertussis infection.

Authors:  A J Gearing; C R Bird; K Redhead; M Thomas
Journal:  FEMS Microbiol Immunol       Date:  1989-03

6.  Placebo-controlled trial of two acellular pertussis vaccines in Sweden--protective efficacy and adverse events. Ad Hoc Group for the Study of Pertussis Vaccines.

Authors: 
Journal:  Lancet       Date:  1988-04-30       Impact factor: 79.321

7.  Bordetella pertussis infection: a cause of persistent cough in adults.

Authors:  P W Robertson; H Goldberg; B H Jarvie; D D Smith; L R Whybin
Journal:  Med J Aust       Date:  1987-05-18       Impact factor: 7.738

8.  Dissecting human T cell responses against Bordetella species.

Authors:  M T De Magistris; M Romano; S Nuti; R Rappuoli; A Tagliabue
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

9.  Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G.

Authors:  A Podda; L Nencioni; M T De Magistris; A Di Tommaso; P Bossù; S Nuti; P Pileri; S Peppoloni; M Bugnoli; P Ruggiero
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

10.  Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis.

Authors:  R D Shahin; M J Brennan; Z M Li; B D Meade; C R Manclark
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  11 in total

1.  Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines.

Authors:  C M Ausiello; R Lande; F Urbani; A la Sala; P Stefanelli; S Salmaso; P Mastrantonio; A Cassone
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection.

Authors:  S Esposito; T Agliardi; A Giammanco; G Faldella; A Cascio; S Bosis; O Friscia; M Clerici; N Principi
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

Review 3.  Waning and aging of cellular immunity to Bordetella pertussis.

Authors:  Inonge van Twillert; Wanda G H Han; Cécile A C M van Els
Journal:  Pathog Dis       Date:  2015-09-13       Impact factor: 3.166

4.  Effects of a diphtheria-tetanus-acellular pertussis vaccine on immune responses in murine local lymph node and lung allergy models.

Authors:  Rob J Vandebriel; Eric R Gremmer; Michiel van Hartskamp; Jan A M A Dormans; Frits R Mooi
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

5.  Human monocytic U937 cells kill Salmonella in vitro by NO-independent mechanisms.

Authors:  P Ekman; M Saarinen; Q He; M Virtala; M Salmi; K Granfors
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

Review 6.  Bordetella filamentous hemagglutinin and fimbriae: critical adhesins with unrealized vaccine potential.

Authors:  Erich V Scheller; Peggy A Cotter
Journal:  Pathog Dis       Date:  2015-09-27       Impact factor: 3.166

7.  A corticoid-sensitive cytokine release assay for monitoring stress-mediated immune modulation.

Authors:  M Feuerecker; W Mayer; I Kaufmann; M Gruber; F Muckenthaler; B Yi; A P Salam; J Briegel; G Schelling; M Thiel; A Choukèr
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

8.  Both CD4⁺ and CD8⁺ lymphocytes participate in the IFN-γ response to filamentous hemagglutinin from Bordetella pertussis in infants, children, and adults.

Authors:  Violette Dirix; Virginie Verscheure; Françoise Vermeulen; Iris De Schutter; Tessa Goetghebuer; Camille Locht; Françoise Mascart
Journal:  Clin Dev Immunol       Date:  2012-04-08

9.  Preliminary study on the immunogenicity of a newly developed GCC Tdap vaccine and its protection efficacy against Bordetella pertussis in a murine intranasal challenge model.

Authors:  Seung Beom Han; Kyu Ri Kang; Dong Ho Huh; Hee Chul Lee; Soo Young Lee; Jong-Hyun Kim; Jae Kyun Hur; Jin Han Kang
Journal:  Clin Exp Vaccine Res       Date:  2015-01-30

10.  Acellular pertussis vaccines and pertussis resurgence: revise or replace?

Authors:  Clara Maria Ausiello; Antonio Cassone
Journal:  MBio       Date:  2014-06-10       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.